Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
Scientific Reports
|
October 1, 2025
Angiopoietin-2 adsorption attempt with the cytokine adsorber cytosorb in critically ill patients
Helen Graf, Caroline Gräfe, Michael Paal, et al.
Annals of Intensive Care
|
May 22, 2022
Does the cytokine adsorber CytoSorb<sup>®</sup> reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study
Christina Scharf, Ferdinand Weinelt, Ines Schroeder, et al.
Antibiotics (Basel, Switzerland)
|
November 27, 2024
Model-Based Dose Identification of Dalbavancin for Long-Term Suppressive Outpatient Treatment of Ventricular Assist Device Infections
Ute Chiriac, Uwe Liebchen, Otto Roman Frey, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 2023
Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
Lea Marie Schatz, Alexander Brinkmann, Anka Röhr, et al.
Antimicrobial Agents and Chemotherapy
|
June 27, 2023
Cefepime Population Pharmacokinetics, Antibacterial Target Attainment, and Estimated Probability of Neurotoxicity in Critically Ill Patients
Muhammad Bilal, Michael Zoller, Uwe Fuhr, et al.
Blood Purification
|
November 7, 2024
Albumin and Platelet Loss during the Application of CytoSorb® in Critically Ill Patients: A post hoc Analysis of the Cyto-SOLVE Trial
Clara Isabell Brozat, Michael Zoller, Sandra Frank, et al.
Frontiers in Cardiovascular Medicine
|
August 23, 2024
Serum concentrations of levosimendan and its metabolites OR-1855 and OR-1896 in cardiac surgery patients with cardiopulmonary bypass
Hannah Kipka, Uwe Liebchen, Max Hübner, et al.
Antibiotics (Basel, Switzerland)
|
July 29, 2023
Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill Patients
Ute Chiriac, Daniel Richter, Otto R Frey, et al.
Clinical Laboratory
|
September 19, 2019
Comparative LC-MS/MS and HPLC-UV Analyses of Meropenem and Piperacillin in Critically Ill Patients
Michael Paal, Marcus Heilmann, Simone Koch, et al.
Intensive Care Medicine Experimental
|
May 8, 2024
Can linezolid be validly measured in endotracheal aspiration in critically ill patients? A proof-of-concept trial
Diana Rebholz, Uwe Liebchen, Michael Paal, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
Scientific Reports
|
October 1, 2025
Angiopoietin-2 adsorption attempt with the cytokine adsorber cytosorb in critically ill patients
Helen Graf, Caroline Gräfe, Michael Paal, et al.
Annals of Intensive Care
|
May 22, 2022
Does the cytokine adsorber CytoSorb<sup>®</sup> reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study
Christina Scharf, Ferdinand Weinelt, Ines Schroeder, et al.
Antibiotics (Basel, Switzerland)
|
November 27, 2024
Model-Based Dose Identification of Dalbavancin for Long-Term Suppressive Outpatient Treatment of Ventricular Assist Device Infections
Ute Chiriac, Uwe Liebchen, Otto Roman Frey, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 2023
Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
Lea Marie Schatz, Alexander Brinkmann, Anka Röhr, et al.
Antimicrobial Agents and Chemotherapy
|
June 27, 2023
Cefepime Population Pharmacokinetics, Antibacterial Target Attainment, and Estimated Probability of Neurotoxicity in Critically Ill Patients
Muhammad Bilal, Michael Zoller, Uwe Fuhr, et al.
Blood Purification
|
November 7, 2024
Albumin and Platelet Loss during the Application of CytoSorb® in Critically Ill Patients: A post hoc Analysis of the Cyto-SOLVE Trial
Clara Isabell Brozat, Michael Zoller, Sandra Frank, et al.
Frontiers in Cardiovascular Medicine
|
August 23, 2024
Serum concentrations of levosimendan and its metabolites OR-1855 and OR-1896 in cardiac surgery patients with cardiopulmonary bypass
Hannah Kipka, Uwe Liebchen, Max Hübner, et al.
Antibiotics (Basel, Switzerland)
|
July 29, 2023
Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill Patients
Ute Chiriac, Daniel Richter, Otto R Frey, et al.
Clinical Laboratory
|
September 19, 2019
Comparative LC-MS/MS and HPLC-UV Analyses of Meropenem and Piperacillin in Critically Ill Patients
Michael Paal, Marcus Heilmann, Simone Koch, et al.
Intensive Care Medicine Experimental
|
May 8, 2024
Can linezolid be validly measured in endotracheal aspiration in critically ill patients? A proof-of-concept trial
Diana Rebholz, Uwe Liebchen, Michael Paal, et al.
Page
of 7